Programme: New Updates in Drug Formulation & Bioavailability

Copenhagen, August 28th

 

Note that changes to the programme may occur. Any changes will be reflected here. Stay up to date by revisiting this page before the event.


 

09:00                 Registration, partnering meetings and networking at the exhibition

09:30                 Welcome and introduction                           

                              Korbinian Löbmann, Chief Scientific Officer and Co-founder, Zerion Pharma

 

09:35                 AI Aptamer API from Design to Delivery

                              Christian Code, Chief Technology Officer, Dianox

 

10:05                 BEPO®, an In-situ Forming Depot Technology for Improved Local Delivery

                              Sylvestre Grizot, Research & Innovation Leader, MedinCell

 

10:35                 Coffee, partnering meetings and networking at the exhibition

 

11:15                 Enhancing Solubility of PROTACs with Polyvinyl Alcohol

                              Markus Lubda, Strategic Product Manager, Merck Life Science KGaA

 

11:45                 To be announced

 

12:15                 Lunch, partnering meetings and networking at the exhibition

 

13:15                 Needle-Free Delivery of Epinephrine – A New and Unique Treament for Anaphylaxis 

                              Robert Rönn, SVP and Head of R&D, Orexo

 

13:45                 Systemic Delivery of Biologics via Inhalation: Overcoming Injection Aversion in Modern Therapies

                              Orest Lastow, Founder and Chief Technology Officer, Iconovo

 

14:15                 Coffee, partnering meetings and networking at the exhibition

 

14:45                 To be announced


 

15:15                 Streamlined and Cost-Efficient Drug Development from Lab to Market with Mesoporous Magnesium Carbonate (MMC)

                              Jonas Fagerberg, Principal Scientist, Disruptive Pharma

 

15:45                 Summary and conclusion